Glucose Intolerance and the Amount of Visceral Adipose Tissue Contribute to an Increase in Circulating Triglyceride Concentrations in Caucasian Obese Females
Context Lipotoxicity is a risk factor for developing obesity-related metabolic complications, including non-alcoholic fatty liver disease, type 2 diabetes (DM2), cardiovascular disease and stroke. Yet, the mechanisms underlying the development of lipotoxicity itself remain poorly understood. Here, we investigated whether glucose intolerance aggravates lipotoxicity by evaluating the association between triglyceride (TG) concentrations and glucose tolerance status in a cross-sectional study on obese Caucasian women at risk for DM2. Methods 913 obese females unknown to have diabetes were recruited (mean age: 41.2±SD 12.3; median BMI: 36.2, IQR 32.9–40.2). Visceral (VAT) and subcutaneous abdominal adipose tissue volumes were quantified with computed tomography. Glucose, insulin, and triglyceride concentrations were determined in fasting state and following a 75 gram oral glucose tolerance test. Results Based on fasting and 2 h post-load glucose levels, 27% of the women had impaired glucose tolerance (IGT), and 8% had newly diagnosed DM2. Fasting TG concentrations were similar between the IGT- and DM2-groups, and increased as compared to women with normal glucose tolerance (NGT). Even when adjusting for age, hip circumference and VAT, fasting TG concentrations remained elevated as compared to NGT. Mixed modelling analysis of post-load responses showed that TG concentrations declined more slowly in the DM2-group as compared to IGT and NGT. However, when adjusting for VAT the difference in decline between the glucose tolerance groups disappeared. Conclusions Glucose intolerance associates with elevated fasting TG concentrations in obese Caucasian women. We propose that glucose intolerance and increased VAT reduce lipid disposal mechanisms and may accelerate lipotoxicity.
References
[1]
Haffner SM, Lehto S, R？nnemaa T, Py？r？l？ K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 339: 229–234.
[2]
Frayn KN (2002) Adipose tissue as a buffer for daily lipid flux. Diabetologia 45: 1201–1210.
[3]
Lodhi IJ, Wei X, Semenkovich CF (2011) Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter. Trends Endocrinol Metab 22: 1–83.
[4]
Van Gaal LF, Mertens IL, De Block CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444: 875–880.
[5]
Karpe F, Dickmann JR, Frayn KN (2011) Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 60: 2441–2449.
[6]
De Naeyer H, Ouwens DM, Van Nieuwenhove Y, Pattyn P, ’t Hart LM, et al. (2011) Combined Gene- and Protein Expression of Hormone-Sensitive Lipase and Adipose Triglyceride Lipase, Mitochondrial Content and Adipocyte Size in Subcutaneous and Visceral Adipose Tissue of Morbidly Obese Men. Obes Facts 4: 407–416.
[7]
Ruige JB, Van Gaal L (2009) Low fasting triglycerides: Hallmark of the Healthy Large Hip? Obesity 17: 1621–1626.
[8]
St-Pierre J, Lemieux I, Perron P, Brisson D, Santuré M, et al. (2007) Relation of the “hypertriglyceridemic waist” phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus. Am J Cardiol 99: 369–373.
[9]
Manolopoulos KN, Karpe F, Frayn KN (2010) Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond) 34: 949–959.
[10]
Lissner L, Bjorkelund C, Heitmann BL, Seidell JC, Bengtsson C (2001) Larger hip circumference independently predicts health and longevity in a Swedish female cohort. Obes Res 9: 644–646.
[11]
Tirosh A, Rudich A, Shochat T, Tekes-Manova D, Israeli E, et al. (2007) Changes in triglyceride levels and risk for coronary heart disease in young men. Ann Intern Med 147: 377–385.
[12]
Tirosh A, Shai I, Bitzur R, Kochba I, Tekes-Manova D, et al. (2008) Changes in triglyceride levels over time and risk of type 2 diabetes in young men. Diabetes Care 31: 2032–2037.
[13]
DeFronzo RA, Abdul-Ghani M (2011) Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am J Cardiol 108(3 Suppl): 3B–24B.
[14]
Lapauw B, Ouwens M, ‘t Hart LM, Wuyts B, Holst JJ, et al. (2010) Sex steroids affect triglyceride handling, glucose-dependent insulinotropic polypeptide, and insulin sensitivity: a 1-week randomized clinical trial in healthy young men. Diabetes Care 33: 1831–1833.
[15]
Third Report of the National Cholesterol Education Program (NCEP) (2002) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143–3421.
[16]
Van der Kooy K, Seidell JC (1993) Techniques for the measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord 17: 187–196.
[17]
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412–419.
[18]
Follow-up Report of the Diagnosis of Diabetes Mellitus (2003) The expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26: 3160–3167.
[19]
Holloway GP, Luiken JJ, Glatz JF, Spriet LL, Bonen A (2008) Contribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview. Acta Physiol (Oxf) 194: 293–309.
[20]
Yu SS, Castillo DC, Courville AB, Sumner AE (2012) The triglyceride paradox in people of african descent. Metab Syndr Relat Disord 10: 77–82.
[21]
Nseir W, Shalata A, Marmor A, Assy N (2011) Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease Dig Dis Sci. 56: 3439–3449.
[22]
Matsushita Y, Nakagawa T, Yamamoto S, Takahashi Y, Yokoyama T, et al. (2012) Effect of longitudinal changes in visceral fat area and other anthropometric indices to the changes in metabolic risk factors in Japanese men: the hitachi health study. Diabetes Care 35: 1139–1143.
[23]
Manco M, Bedogni G, Marcellini M, Devito R, Ciampalini P, et al. (2008) Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis. Gut 57: 1283–1287.
[24]
McQuaid SE, Hodson L, Neville MJ, Dennis AL, Cheeseman J, et al. (2011) Downregulation of adipose tissue fatty acid trafficking in obesity. A driver for ectopic fat deposition? Diabetes 60: 47–55.
[25]
Perreault L, Bergman BC, Hunerdosse DM, Playdon MC, Eckel RH (2010) Inflexibility in intramuscular triglyceride fractional synthesis distinguishes prediabetes from obesity in humans. Obesity (Silver Spring). 18: 1524–1531.
[26]
Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350: 664–671.
